Ten-year survival after resection for lung carcinoma: Effect of blood transfusion and tumour stage on outcome

Scandinavian Cardiovascular Journal

Volumn 30, Issue 2, 1996, Pages 87-91

  Rainio, P ^a   Bloigu, R ^a   Satta, J ^a   Pokela, R ^a   PaaP ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

bfood transfirsion; Lung carcinoma; surgical treatment; survival

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER STAGING; CANCER SURVIVAL; CIGARETTE SMOKING; FEMALE; FINLAND; HUMAN; LUNG CARCINOMA; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CARCINOMA, SQUAMOUS CELL; CAUSE OF DEATH; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTRAOPERATIVE CARE; LUNG NEOPLASMS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POSTOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030056123     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017439609107248     Document Type: Article

References (29)

1. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrence rate. Lancet 1982;2:662.
2. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
3. Denoix PF. Enquete permanent dans les centres anticancereux. Bull Inst nat Hyg 1946;1:70-76.
4. Dupont E, Vereerstraeten P, Espinosa O et al. Multiple transfusions and T cell subsets: A role for ferritin? Transplantation 1983;35:508-510. (Pubitemid 13089931)
5. Gehan E. A generalized Wilcoxon test for comparing arbitrarily single-censored samples. Biometrika 1965;52:203-224.
6. Harmer EM. TNM classification of malignant tumors. Geneve: Union Internationale Contre le Cancer, 1978:41-45.
7. Humphrey EW, Smart CR, Winchester DP, et al. National survey of the pattern of care for carcinoma of the lung. J Thorac Cardiovasc Surg 1990;100:837-843.
8. Hyman NH, Foster RS Jr, DeMeules JE, Costanza MC. Blood transfusions and survival after lung cancer resection. Am J Surg 1985;149:502-527.
9. Ishida T, Yano T, Maeda K, Kaneko S, Tateishi M, Sugimachi K. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 1990;50:708-713. (Pubitemid 20367728)
10. Izbicki JR, Passlick B, Karg O, Bloechle C, Pantel K, Knoefel WT, Thetter O. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995;59:209-214.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
12. Keller SM, Groshen S, Martini N, Kaiser LR. Blood transfusion and lung cancer recurrence. Cancer 1988;62:606-610.
13. Kirschner P. Does transfusion modify the outcome of cancer resections? Ann Thorac Surg 1989;47:336-337. (Pubitemid 19100459)
14. Little AG, Wu H-S, Ferguson MK, Ho C-H, Bowers VD, Segalin A, Staszek VM. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg 1990;160:630-633.
15. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch V, Ginsberg RJ. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
16. Martini N, Burt ME, Bains MS, McCormack PM, Rusch VW, Ginsberg RJ. Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 1992;54:460-466.
17. Miller DL, Orszulak TA, Pairolero PC, Trastek VF, Schaff HV. Combined operation for lung cancer and cardiac disease. Ann Thorac Surg 1994;58:989-994. (Pubitemid 24342418)
18. Moores DWO, Piantadosi S, McKneally MF, for the Lung Cancer Study Group. Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg 1989;47:346-351. (Pubitemid 19100462)
19. Mori K, Yanase N, Kaneko M, Ono R, Ikeda S. Diagnosis of peripheral lung cancer in cases of tumors 2 cm or less in size. Chest 1989;95:304-308. (Pubitemid 19051407)
20. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-33S. (Pubitemid 16138265)
21. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac and Cardiovasc Surg 1978;76(6):832-839. (Pubitemid 9084851)
22. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-447.
23. Nowak MM, Ponsky JL. Blood transfusion and disease-free survival in carcinoma of the breast. J Surg Oncol 1984;27:124-130. (Pubitemid 15201665)
24. Opelz G, Terasaki PI. Improvement of kidney graft survival with increased numbers of blood transfusions. N Engl J Med 1978;299:799-804.
25. Potaznik D, de Sousa M, Helson L et al. Ferritin in neuroblastoma. Impact of tumor load and blood transfusions. Cancer Invest 1985;3:327-338. (Pubitemid 15235604)
26. Read RC, Yoder G, Schaeffer RC. Survival after conservative resection for Tl NO MO non-small cell lung cancer. Ann Thorac Surg 1990;49:391-400. (Pubitemid 20097030)
27. Staszek VM. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Ann J Surg 1990;160:630-632.
28. Tartter PI, Burrows L, Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset no) non-oat cell lung cancer. J Thorac Cardiovasc Surg 1984;88:659-662. (Pubitemid 15219246)
29. World Health Organization. Histological typing of lung tumours. 2nd ed. International histological classification of tumours. No 1. Geneva: World Health Organization, 1981.